Company news

Cabaletta Bio, Inc. news in 2024

Cabaletta Bio, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Cabaletta Bio to Participate in Upcoming Investor Conferences in December

November 25, 2024

Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024

November 17, 2024

Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update

November 13, 2024

Cabaletta Bio to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference

November 5, 2024

Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024

September 24, 2024

Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update

August 7, 2024

Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum

July 1, 2024

Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201

June 13, 2024

Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update

May 14, 2024

Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

May 12, 2024

Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

March 20, 2024

Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis

March 19, 2024

Cabaletta Bio to Participate in Upcoming Investor Conferences in March

February 26, 2024

Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis

January 31, 2024

Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

January 30, 2024

Cabaletta Bio Receives Additional FDA Fast Track Designations for CABA-201 in Dermatomyositis and Systemic Sclerosis

January 7, 2024

Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 1, 2024

Calls in 2024

Decks in 2024